4 NEW MEMBERS NAMED TO NIAID ADVISORY COUNCIL

[Guest guest]

FOUR NEW MEMBERS NAMED TO NIAID ADVISORY COUNCIL

Date: Mon, 13 Feb 2006 16:17:41 -0500

Subject: FOUR NEW MEMBERS NAMED TO NIAID ADVISORY COUNCIL

U.S. Department of Health and Human Services

NATIONAL INSTITUTES OF HEALTH

NIH News

National Institute of Allergy and Infectious Diseases (NIAID)

http://www3.niaid.nih.gov/

FOR IMMEDIATE RELEASE: Monday, February 13, 2006

CONTACT: NIAID News Office, , niaidnews@...

FOUR NEW MEMBERS NAMED TO NIAID ADVISORY COUNCIL

The National Institute of Allergy and Infectious Diseases (NIAID)

today

announced the appointment of four new members to the National

Advisory Allergy

and Infectious Diseases Council, its principal advisory body. NIAID

is part of

the National Institutes of Health (NIH), an agency within the

Department of

Health and Human Services.

The council provides recommendations on the conduct and support of

research,

including training young scientists and disseminating health

information derived

from NIAID research. It embodies a diverse perspective on science,

health and

the human impact of disease. The council is composed of physicians,

scientists

and representatives of the public who contribute their time and

expertise for a

four-year term.

The new council members are Barbara A. Baird, Ph.D., of Cornell

University in

Ithaca, NY; M. , M.D., of Vanderbilt University in

Nashville, TN;

Rosenberg, Ph.D., of Promega Corporation in Madison, WI; and

Sykes,

M.D., of Harvard Medical School in Boston.

Dr. Baird is a professor in the department of chemistry and chemical

biology at

Cornell University. She also serves as director of the

Nanobiotechnology Center

and is principal investigator for Cornell's training grant in

molecular

biophysics. Dr. Baird's research laboratory uses biochemical and

biophysical

approaches to investigate basic mechanisms of cell surface receptors

in

mediating transmembrane signals in immune responses. A primary focus

of the

laboratory's research is the high-affinity receptor for

immunoglobulin E. She

works closely with other interdisciplinary scientists and engineers

to develop

new technologies and quantitative approaches to cell biology

problems.

Dr. is professor of pediatrics at Vanderbilt University. She

was the

principal investigator of the NIAID-funded, placebo-controlled

influenza

efficacy trial comparing live, attenuated and inactivated influenza

vaccines in

more than 3,000 volunteers. She is now studying the impact of

vaccination

programs on disease burden and leads the NIAID-supported Vaccine and

Treatment

Evaluation Unit at Vanderbilt. She served on the Advisory Committee

on

Immunization Practices of the Centers for Disease Control and

Prevention; the

Vaccine and Related Biologic Products Advisory Committee of the Food

and Drug

Administration; and the Institute of Medicine Committee for the

Evaluation of

the Safety and Effectiveness of the Anthrax Vaccine.

Dr. Rosenberg is chief scientific officer of Promega Corporation in

Wisconsin.

He serves on the boards of directors for Promega Corporation; Cubist

Pharmaceuticals; the Medical College of Wisconsin Research

Foundation; Nereus

Pharmaceuticals; Anacor Pharmaceuticals; and Scarab Genomics. He is

also on

various academic and industry scientific advisory boards and is

editor of both

" Current Opinions in Biotechnology " and the " Journal of

Bacteriology " . Dr.

Rosenberg is an adjunct professor in the department of bacteriology

at the

University of Wisconsin and in the department of biochemistry at the

Woods Medical School.

Dr. Sykes is the Harold and Ellen Danser Professor in the department

of surgery

and a professor of medicine at Harvard Medical School. She is an

immunologist

and associate director of the Transplantation Biology Research

Center at

Massachusetts General Hospital. Her research is in the areas of

hematopoietic

cell transplantation; achievement of graft-versus-leukemia effects

without

graft-versus-host disease; organ allograft tolerance induction; and

xenotransplantation. Dr. Sykes is president of the International

Xenotransplantation Association and a councilor of the International

Transplantation Society.

News releases, fact sheets and other NIAID-related materials are

available on

the NIAID Web site at http://www.niaid.nih.gov.

NIAID is a component of the National Institutes of Health, an agency

of the U.S.

Department of Health and Human Services. NIAID supports basic and

applied

research to prevent, diagnose and treat infectious diseases such as

HIV/AIDS and

other sexually transmitted infections, influenza, tuberculosis,

malaria and

illness from potential agents of bioterrorism. NIAID also supports

research on

transplantation and immune-related illnesses, including autoimmune

disorders,

asthma and allergies.

The National Institutes of Health (NIH) - The Nation's Medical

Research Agency -

is a component of the U. S. Department of Health and Human Services.

It is the

primary Federal agency for conducting and supporting basic,

clinical, and

translational medical research, and it investigates the causes,

treatments, and

cures for both common and rare diseases. For more information about

NIH and its

programs, visit http://www.nih.gov.

##

This NIH News Release is available online at:

http://www.nih.gov/news/pr/feb2006/niaid-13.htm.